Trial Profile
A Phase II Trial of Rituximab In Myasthenia Gravis
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2014
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Myasthenia gravis
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- 29 Jun 2014 New trial record